{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:04:54Z","timestamp":1782273894130,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ejmech.2022.114694","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T17:57:25Z","timestamp":1662400645000},"page":"114694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Discovery of a novel water-soluble, rapid-release triptolide prodrug with improved drug-like properties and high efficacy in human acute myeloid leukemia"],"prefix":"10.1016","volume":"243","author":[{"given":"Di","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7526-325X","authenticated-orcid":false,"given":"Junwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.114694_bib1","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1021\/ja00775a078","article-title":"Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordii","volume":"94","author":"Kupchan","year":"1972","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2022.114694_bib2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.intimp.2011.01.012","article-title":"Triptolide and its expanding multiple pharmacological functions","volume":"11","author":"Liu","year":"2011","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejmech.2022.114694_bib3","first-page":"149","article-title":"Immunosuppressive, anti-inflammatory and anti-cancer properties of triptolide: a mini review","volume":"6","author":"Ziaei","year":"2016","journal-title":"Avicenna. J. Phytomed."},{"key":"10.1016\/j.ejmech.2022.114694_bib4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11655-018-2847-z","article-title":"Triptolide, A potential autophagy modulator","volume":"25","author":"Wei","year":"2019","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.ejmech.2022.114694_bib5","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1039\/c2np00088a","article-title":"Triptolide: structural modifications, structure-activity relationships, bioactivities, clinical development and mechanisms","volume":"29","author":"Zhou","year":"2012","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2022.114694_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.152953","article-title":"Triptolide enhances TRAIL sensitivity of pancreatic cancer cells by activating autophagy via downregulation of PUM1","volume":"62","author":"Dai","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2022.114694_bib7","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.3727\/096504018X15179661552702","article-title":"Triptolide inhibits proliferation and migration of human neuroblastoma SH-SY5Y cells by upregulating MicroRNA-181a","volume":"26","author":"Jiang","year":"2018","journal-title":"Oncol. Res."},{"key":"10.1016\/j.ejmech.2022.114694_bib8","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1248\/bpb.b18-00818","article-title":"Triptolide suppresses growth of breast cancer by targeting HMGB1 in vitro and in vivo","volume":"42","author":"Jiang","year":"2019","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2022.114694_bib9","first-page":"2519","article-title":"Triptolide promotes senescence of prostate cancer cells through histone methylation and heterochromatin formation","volume":"18","author":"Tamgue","year":"2017","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.ejmech.2022.114694_bib10","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.biopha.2017.04.003","article-title":"Toxicity of triptolide and the molecular mechanisms involved","volume":"90","author":"Xi","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2022.114694_bib11","doi-asserted-by":"crossref","first-page":"6095","DOI":"10.2147\/DDDT.S92022","article-title":"Protective effects of triptolide on retinal ganglion cells in a rat model of chronic glaucoma","volume":"9","author":"Yang","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2022.114694_bib12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.fitote.2014.01.006","article-title":"Th17\/Treg imbalance in triptolide-induced liver injury","volume":"93","author":"Wang","year":"2014","journal-title":"Fitoterapia"},{"key":"10.1016\/j.ejmech.2022.114694_bib13","article-title":"Activation of Nrf2 protects against triptolide-induced hepatotoxicity","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2022.114694_bib14","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.etp.2011.03.013","article-title":"Involvement of oxidative stress in the mechanism of triptolide-induced acute nephrotoxicity in rats","volume":"64","author":"Yang","year":"2012","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.ejmech.2022.114694_bib15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2174\/157019312800604661","article-title":"Bio-activities and syntheses developments of triptolides","volume":"9","author":"Chen","year":"2012","journal-title":"Mini-Reviews Org. Chem."},{"key":"10.1016\/j.ejmech.2022.114694_bib16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s13659-016-0100-z","article-title":"Catalytic asymmetric formal total synthesis of (-)-Triptophenolide and (+)-Triptolide","volume":"6","author":"Xu","year":"2016","journal-title":"Nat. Prod. Bioprospect."},{"key":"10.1016\/j.ejmech.2022.114694_bib17","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1021\/jo00133a026","article-title":"Total synthesis of racemic triptolide and triptonide","volume":"47","author":"Lai","year":"1982","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2022.114694_bib18","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1021\/jo00435a008","article-title":"Studies on the total synthesis of triptolide. I","volume":"42","author":"Sher","year":"1977","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2022.114694_bib19","doi-asserted-by":"crossref","first-page":"10110","DOI":"10.1021\/jo501744j","article-title":"Divergent total synthesis of triptolide, triptonide, tripdiolide, 16-hydroxytriptolide, and their analogues","volume":"79","author":"Xu","year":"2014","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2022.114694_bib20","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1016\/j.tet.2014.03.070","article-title":"Synthesis and biological evaluation of 20-hydroxytriptonide and its analogues","volume":"70","author":"Xu","year":"2014","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2022.114694_bib21","doi-asserted-by":"crossref","first-page":"7118","DOI":"10.1016\/j.tetlet.2014.11.010","article-title":"Metal-mediate reactions based formal synthesis of triptonide and triptolide","volume":"55","author":"Xu","year":"2014","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2022.114694_bib22","doi-asserted-by":"crossref","first-page":"6865","DOI":"10.1016\/S0040-4039(97)01581-5","article-title":"Studies on triepoxide analogs of triptolide","volume":"38","author":"Yang","year":"1997","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2022.114694_bib23","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1039\/C3OB42183J","article-title":"New facile enantio- and diastereo-selective syntheses of (-)-triptonide and (-)-triptolide","volume":"12","author":"Zhang","year":"2014","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2022.114694_bib24","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1021\/acs.orglett.6b00968","article-title":"Gold-catalyzed photoredox C(sp(2)) cyclization: formal synthesis of (\u00b1)-Triptolide","volume":"18","author":"Cannillo","year":"2016","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2022.114694_bib25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nchembio.522","article-title":"XPB, a subunit of TFIIH, is a target of the natural product triptolide","volume":"7","author":"Titov","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2022.114694_bib26","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/anie.201408817","article-title":"Covalent modification of a cysteine residue in the XPB subunit of the general transcription factor TFIIH through single epoxide cleavage of the transcription inhibitor triptolide","volume":"54","author":"He","year":"2015","journal-title":"Angew. Chem., Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2022.114694_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.811850","article-title":"Triptolide shows high sensitivity and low toxicity against acute myeloid leukemia cell lines through inhibiting WSTF-RNAPII complex","volume":"12","author":"Kang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2022.114694_bib28","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/cbdv.200900114","article-title":"Prodrug approaches for enhancing the bioavailability of drugs with low solubility","volume":"6","author":"M\u00fcller","year":"2009","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejmech.2022.114694_bib29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/molecules21010042","article-title":"The prodrug approach: a successful tool for improving drug solubility","volume":"21","author":"Jornada","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.114694_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118498","article-title":"Is prodrug design an approach to increase water solubility?","volume":"568","author":"Sanches","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejmech.2022.114694_bib31","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.ejca.2009.01.026","article-title":"Phase I dose-escalation study of F60008, a novel apoptosis inducer, in patients with advanced solid tumours","volume":"45","author":"Kitzen","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejmech.2022.114694_bib32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jep.2013.08.018","article-title":"Simultaneous determination of triptolide and its prodrug MC002 in dog blood by LC-MS\/MS and its application in pharmacokinetic studies","volume":"150","author":"Zhuang","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2022.114694_bib33","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/j.bmc.2010.01.052","article-title":"Design, synthesis, and biological evaluation of novel water-soluble triptolide derivatives: antineoplastic activity against imatinib-resistant CML cells bearing T315I mutant Bcr-Abl","volume":"18","author":"Xu","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114694_bib34","doi-asserted-by":"crossref","first-page":"9334","DOI":"10.1021\/acs.jmedchem.5b01329","article-title":"Phosphonooxymethyl prodrug of triptolide: synthesis, physicochemical characterization, and efficacy in human colon adenocarcinoma and ovarian cancer xenografts","volume":"58","author":"Patil","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114694_bib35","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/pros.23298","article-title":"Minnelide inhibits androgen dependent, castration resistant prostate cancer growth by decreasing expression of androgen receptor full length and splice variants","volume":"77","author":"Isharwal","year":"2017","journal-title":"Prostate"},{"key":"10.1016\/j.ejmech.2022.114694_bib36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12967-019-1901-8","article-title":"Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia","volume":"17","author":"Giri","year":"2019","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejmech.2022.114694_bib37","first-page":"2202","article-title":"Minnelide, a prodrug, inhibits cervical cancer growth by blocking HPV-induced changes in p53 and pRb","volume":"11","author":"Ramakrishnan","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.ejmech.2022.114694_bib38","doi-asserted-by":"crossref","first-page":"7857","DOI":"10.1021\/acs.jmedchem.0c00698","article-title":"Design, synthesis, and activity study of water-soluble, rapid-release propofol prodrugs","volume":"63","author":"Liu","year":"2020","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422005967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422005967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:46:23Z","timestamp":1759329983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422005967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":38,"alternative-id":["S0223523422005967"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114694","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of a novel water-soluble, rapid-release triptolide prodrug with improved drug-like properties and high efficacy in human acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114694","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114694"}}